25 XP   0   0   10

Reviva Pharmaceuticals Holdings Inc.
Buy, Hold or Sell?

Let's analyse Reviva Pharmaceuticals Holdings Inc. together

PenkeI guess you are interested in Reviva Pharmaceuticals Holdings Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Reviva Pharmaceuticals Holdings Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Reviva Pharmaceuticals Holdings Inc.

I send you an email if I find something interesting about Reviva Pharmaceuticals Holdings Inc..

Quick analysis of Reviva Pharmaceuticals Holdings Inc. (30 sec.)










What can you expect buying and holding a share of Reviva Pharmaceuticals Holdings Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.44
Expected worth in 1 year
$-1.90
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
$-2.35
Return On Investment
-77.7%

For what price can you sell your share?

Current Price per Share
$3.02
Expected price per share
$1.56 - $4.07
How sure are you?
50%

1. Valuation of Reviva Pharmaceuticals Holdings Inc. (5 min.)




Live pricePrice per Share (EOD)

$3.02

Intrinsic Value Per Share

$-11.20 - $-13.43

Total Value Per Share

$-10.76 - $-12.99

2. Growth of Reviva Pharmaceuticals Holdings Inc. (5 min.)




Is Reviva Pharmaceuticals Holdings Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$12.3m$28.6m-$16.3m-132.9%

How much money is Reviva Pharmaceuticals Holdings Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$24.3m-$8.5m-$15.8m-65.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Reviva Pharmaceuticals Holdings Inc. (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#650 / 1010

Most Revenue
#836 / 1010

Most Profit
#737 / 1010

Most Efficient
#284 / 1010

What can you expect buying and holding a share of Reviva Pharmaceuticals Holdings Inc.? (5 min.)

Welcome investor! Reviva Pharmaceuticals Holdings Inc.'s management wants to use your money to grow the business. In return you get a share of Reviva Pharmaceuticals Holdings Inc..

What can you expect buying and holding a share of Reviva Pharmaceuticals Holdings Inc.?

First you should know what it really means to hold a share of Reviva Pharmaceuticals Holdings Inc.. And how you can make/lose money.

Speculation

The Price per Share of Reviva Pharmaceuticals Holdings Inc. is $3.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Reviva Pharmaceuticals Holdings Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Reviva Pharmaceuticals Holdings Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.44. Based on the TTM, the Book Value Change Per Share is $-0.59 per quarter. Based on the YOY, the Book Value Change Per Share is $0.76 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Reviva Pharmaceuticals Holdings Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.87-28.9%-0.87-28.9%-0.31-10.1%-0.34-11.1%-0.34-11.1%
Usd Book Value Change Per Share-0.59-19.4%-0.59-19.4%0.7625.2%0.113.7%0.113.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.59-19.4%-0.59-19.4%0.7625.2%0.113.7%0.113.7%
Usd Price Per Share4.25-4.25-2.89-6.59-6.59-
Price to Earnings Ratio-4.88--4.88--9.47--105.92--105.92-
Price-to-Total Gains Ratio-7.25--7.25-3.80--7.30--7.30-
Price to Book Ratio9.63-9.63-2.81-0.60-0.60-
Price-to-Total Gains Ratio-7.25--7.25-3.80--7.30--7.30-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.02
Number of shares331
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.590.11
Usd Total Gains Per Share-0.590.11
Gains per Quarter (331 shares)-194.0836.51
Gains per Year (331 shares)-776.33146.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-776-7860146136
20-1553-15620292282
30-2329-23380438428
40-3105-31140584574
50-3882-38900730720
60-4658-46660876866
70-5434-5442010221012
80-6211-6218011681158
90-6987-6994013141304
100-7763-7770014601450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.04.00.00.0%0.04.00.00.0%0.04.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%2.02.00.050.0%2.02.00.050.0%2.02.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.04.00.0%0.00.04.00.0%0.00.04.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%2.02.00.050.0%2.02.00.050.0%2.02.00.050.0%

Fundamentals of Reviva Pharmaceuticals Holdings Inc.

About Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention"deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company was founded in 2018 and is based in Cupertino, California.

Fundamental data was last updated by Penke on 2024-04-12 17:42:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Reviva Pharmaceuticals Holdings Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Reviva Pharmaceuticals Holdings Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y--449.1%+449.1%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Reviva Pharmaceuticals Holdings Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • -128.6% Return on Assets means that Reviva Pharmaceuticals Holdings Inc. generated $-1.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is -128.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -128.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-128.6%TTM-128.6%0.0%
TTM-128.6%YOY-27.1%-101.5%
TTM-128.6%5Y-8,192.3%+8,063.7%
5Y-8,192.3%10Y-8,192.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.6%-13.3%-115.3%
TTM-128.6%-12.8%-115.8%
YOY-27.1%-11.7%-15.4%
5Y-8,192.3%-13.9%-8,178.4%
10Y-8,192.3%-15.7%-8,176.6%
1.1.3. Return on Equity

Shows how efficient Reviva Pharmaceuticals Holdings Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • -197.6% Return on Equity means Reviva Pharmaceuticals Holdings Inc. generated $-1.98 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is -197.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -197.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-197.6%TTM-197.6%0.0%
TTM-197.6%YOY-29.7%-167.9%
TTM-197.6%5Y-69.6%-128.1%
5Y-69.6%10Y-69.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-197.6%-16.9%-180.7%
TTM-197.6%-16.1%-181.5%
YOY-29.7%-15.1%-14.6%
5Y-69.6%-19.3%-50.3%
10Y-69.6%-20.2%-49.4%

1.2. Operating Efficiency of Reviva Pharmaceuticals Holdings Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Reviva Pharmaceuticals Holdings Inc. is operating .

  • Measures how much profit Reviva Pharmaceuticals Holdings Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y--492.1%+492.1%
10Y--632.4%+632.4%
1.2.2. Operating Ratio

Measures how efficient Reviva Pharmaceuticals Holdings Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y-5.739-5.739
10Y-7.876-7.876

1.3. Liquidity of Reviva Pharmaceuticals Holdings Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Reviva Pharmaceuticals Holdings Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.13 means the company has $3.13 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 3.133. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.133. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.133TTM3.1330.000
TTM3.133YOY13.393-10.260
TTM3.1335Y5.775-2.642
5Y5.77510Y5.7750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1333.890-0.757
TTM3.1334.173-1.040
YOY13.3935.344+8.049
5Y5.7756.126-0.351
10Y5.7756.448-0.673
1.3.2. Quick Ratio

Measures if Reviva Pharmaceuticals Holdings Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • A Quick Ratio of 3.07 means the company can pay off $3.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 3.066. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.066. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.066TTM3.0660.000
TTM3.066YOY12.661-9.595
TTM3.0665Y7.969-4.903
5Y7.96910Y7.9690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0663.514-0.448
TTM3.0663.998-0.932
YOY12.6615.380+7.281
5Y7.9696.105+1.864
10Y7.9696.404+1.565

1.4. Solvency of Reviva Pharmaceuticals Holdings Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Reviva Pharmaceuticals Holdings Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.35 means that Reviva Pharmaceuticals Holdings Inc. assets are financed with 34.9% credit (debt) and the remaining percentage (100% - 34.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 0.349. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.349. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.349TTM0.3490.000
TTM0.349YOY0.087+0.263
TTM0.3495Y655.342-654.993
5Y655.34210Y655.3420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3490.339+0.010
TTM0.3490.336+0.013
YOY0.0870.271-0.184
5Y655.3420.366+654.976
10Y655.3420.389+654.953
1.4.2. Debt to Equity Ratio

Measures if Reviva Pharmaceuticals Holdings Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 53.6% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The MRQ is 0.536. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.536. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.536TTM0.5360.000
TTM0.536YOY0.095+0.442
TTM0.5365Y0.203+0.334
5Y0.20310Y0.2030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5360.388+0.148
TTM0.5360.402+0.134
YOY0.0950.335-0.240
5Y0.2030.426-0.223
10Y0.2030.461-0.258

2. Market Valuation of Reviva Pharmaceuticals Holdings Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Reviva Pharmaceuticals Holdings Inc. generates.

  • Above 15 is considered overpriced but always compare Reviva Pharmaceuticals Holdings Inc. to the Biotechnology industry mean.
  • A PE ratio of -4.88 means the investor is paying $-4.88 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The EOD is -3.464. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.875. Based on the earnings, the company is expensive. -2
  • The TTM is -4.875. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.464MRQ-4.875+1.411
MRQ-4.875TTM-4.8750.000
TTM-4.875YOY-9.468+4.593
TTM-4.8755Y-105.921+101.046
5Y-105.92110Y-105.9210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.464-2.264-1.200
MRQ-4.875-2.629-2.246
TTM-4.875-2.680-2.195
YOY-9.468-4.145-5.323
5Y-105.921-6.257-99.664
10Y-105.921-6.254-99.667
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The EOD is -4.447. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.258. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.258. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.447MRQ-6.258+1.811
MRQ-6.258TTM-6.2580.000
TTM-6.258YOY-7.563+1.305
TTM-6.2585Y-354.043+347.785
5Y-354.04310Y-354.0430.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.447-2.973-1.474
MRQ-6.258-3.333-2.925
TTM-6.258-3.553-2.705
YOY-7.563-5.605-1.958
5Y-354.043-8.376-345.667
10Y-354.043-8.865-345.178
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Reviva Pharmaceuticals Holdings Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 9.63 means the investor is paying $9.63 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Reviva Pharmaceuticals Holdings Inc.:

  • The EOD is 6.846. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.634. Based on the equity, the company is overpriced. -1
  • The TTM is 9.634. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.846MRQ9.634-2.788
MRQ9.634TTM9.6340.000
TTM9.634YOY2.813+6.821
TTM9.6345Y0.604+9.030
5Y0.60410Y0.6040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.8461.896+4.950
MRQ9.6342.115+7.519
TTM9.6342.093+7.541
YOY2.8132.884-0.071
5Y0.6043.542-2.938
10Y0.6043.916-3.312
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Reviva Pharmaceuticals Holdings Inc..

3.1. Institutions holding Reviva Pharmaceuticals Holdings Inc.

Institutions are holding 18.791% of the shares of Reviva Pharmaceuticals Holdings Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Armistice Capital, LLC6.31840.12417640001164000194
2023-12-31Vanguard Group Inc3.49220.000197498235905058.2938
2023-12-31Millennium Management LLC2.87230.001880190637877489.5167
2023-12-31Susquehanna International Group, LLP0.73680.00022057122057120
2023-12-31Rosalind Advisors, Inc.0.70310.83261963001963000
2023-12-31Geode Capital Management, LLC0.64050.000117880676144.4476
2023-09-30Colony Group LLC0.61250.01251710001600010.3226
2023-12-31EMC Capital Management(TX)0.44380.426312391500
2023-12-31The Colony Group LLC0.43340.00821210001210000
2023-12-31Woodline Partners LP0.43130.00671204001204000
2023-12-31BlackRock Inc0.330409223835484.0005
2023-12-31State Street Corporation0.23460655002110047.5225
2023-12-31Man Group PLC0.17620.000749196491960
2023-12-31SIMPLEX TRADING, LLC0.16190.00024521240129.7379
2023-12-31Two Sigma Investments LLC0.1490.00054159926299171.8889
2023-12-31Northern Trust Corp0.1441040224886928.2858
2023-12-31Marshall Wace Asset Management Ltd0.14010.000339100391000
2023-12-31Tower Research Capital LLC0.13630.002438043380430
2023-12-31Qube Research & Technologies0.12670.000435364323381068.6715
2023-12-31JANE STREET GROUP, LLC0.1042029091290910
Total 18.38781.4175133588+2820446+54.9%

3.2. Funds holding Reviva Pharmaceuticals Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.50890.000270044200
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.90410.000925241900
2024-02-29Fidelity Extended Market Index0.36250.001101209-490-0.4818
2023-09-30BlackRock Extended Mkt Composite0.19770.00195518900
2024-03-31BlackRock Extended Equity Market K0.17250.001348165170.0353
2024-02-29Fidelity Total Market Index0.1150.00013211700
2024-03-28iShares Micro-Cap ETF0.11360.0133172700
2024-02-29Fidelity Series Total Market Index0.08670.00012421600
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07940.001822177886966.6441
2024-02-29Fidelity Nasdaq Composite Index0.06380.00041782200
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.06380.001817811714366.9573
2023-12-31NT Ext Equity Mkt Idx Fd - L0.060.00151675000
2023-12-31Northern Trust Extended Eq Market Idx0.060.00151675000
2024-02-29Spartan Total Market Index Pool E0.03460.0001965400
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03450.0001961800
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.03450.00029618-362944-97.4184
2023-12-31SSgA U.S. Extended Market Index Class I0.02610.001473005000217.3913
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02460.0001686300
2024-02-29Spartan Extended Market Index Pool E0.02170.000960504908.8129
2024-03-31Extended Equity Market Fund M0.02130.00135941-12-0.2016
Total 4.98530.02961391838-341927-24.6%

3.3. Insider Transactions

Insiders are holding 17.768% of the shares of Reviva Pharmaceuticals Holdings Inc..

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-11-18Purav PatelBUY30004.69
2022-09-30Prabhu NarayanBUY500001.66
2022-06-30Prabhu NarayanBUY500001.21

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Reviva Pharmaceuticals Holdings Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.586-0.5860%0.761-177%0.110-632%0.110-632%
Book Value Per Share--0.4410.4410%1.028-57%0.373+18%0.373+18%
Current Ratio--3.1333.1330%13.393-77%5.775-46%5.775-46%
Debt To Asset Ratio--0.3490.3490%0.087+303%655.342-100%655.342-100%
Debt To Equity Ratio--0.5360.5360%0.095+466%0.203+165%0.203+165%
Dividend Per Share----0%-0%-0%-0%
Eps---0.872-0.8720%-0.305-65%-0.336-61%-0.336-61%
Free Cash Flow Per Share---0.679-0.6790%-0.382-44%-0.301-56%-0.301-56%
Free Cash Flow To Equity Per Share---0.400-0.4000%0.750-153%0.165-343%0.165-343%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---13.431--------
Intrinsic Value_10Y_min---11.202--------
Intrinsic Value_1Y_max---0.604--------
Intrinsic Value_1Y_min---0.587--------
Intrinsic Value_3Y_max---2.380--------
Intrinsic Value_3Y_min---2.238--------
Intrinsic Value_5Y_max---4.838--------
Intrinsic Value_5Y_min---4.396--------
Market Cap84314172.000-41%118654050.000118654050.0000%80684754.000+47%183843981.000-35%183843981.000-35%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio6.846-41%9.6349.6340%2.813+243%0.604+1495%0.604+1495%
Pe Ratio-3.464+29%-4.875-4.8750%-9.468+94%-105.921+2073%-105.921+2073%
Price Per Share3.020-41%4.2504.2500%2.890+47%6.585-35%6.585-35%
Price To Free Cash Flow Ratio-4.447+29%-6.258-6.2580%-7.563+21%-354.043+5558%-354.043+5558%
Price To Total Gains Ratio-5.151+29%-7.248-7.2480%3.796-291%-7.298+1%-7.298+1%
Quick Ratio--3.0663.0660%12.661-76%7.969-62%7.969-62%
Return On Assets---1.286-1.2860%-0.271-79%-81.923+6270%-81.923+6270%
Return On Equity---1.976-1.9760%-0.297-85%-0.696-65%-0.696-65%
Total Gains Per Share---0.586-0.5860%0.761-177%0.110-632%0.110-632%
Usd Book Value--12316396.00012316396.0000%28686460.000-57%10405240.250+18%10405240.250+18%
Usd Book Value Change Per Share---0.586-0.5860%0.761-177%0.110-632%0.110-632%
Usd Book Value Per Share--0.4410.4410%1.028-57%0.373+18%0.373+18%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.872-0.8720%-0.305-65%-0.336-61%-0.336-61%
Usd Free Cash Flow---18960581.000-18960581.0000%-10668462.000-44%-8393294.750-56%-8393294.750-56%
Usd Free Cash Flow Per Share---0.679-0.6790%-0.382-44%-0.301-56%-0.301-56%
Usd Free Cash Flow To Equity Per Share---0.400-0.4000%0.750-153%0.165-343%0.165-343%
Usd Market Cap84314172.000-41%118654050.000118654050.0000%80684754.000+47%183843981.000-35%183843981.000-35%
Usd Price Per Share3.020-41%4.2504.2500%2.890+47%6.585-35%6.585-35%
Usd Profit---24339292.000-24339292.0000%-8521876.000-65%-9372847.000-61%-9372847.000-61%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.586-0.5860%0.761-177%0.110-632%0.110-632%
 EOD+3 -5MRQTTM+0 -0YOY+3 -265Y+7 -2210Y+7 -22

4.2. Fundamental Score

Let's check the fundamental score of Reviva Pharmaceuticals Holdings Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.464
Price to Book Ratio (EOD)Between0-16.846
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.066
Current Ratio (MRQ)Greater than13.133
Debt to Asset Ratio (MRQ)Less than10.349
Debt to Equity Ratio (MRQ)Less than10.536
Return on Equity (MRQ)Greater than0.15-1.976
Return on Assets (MRQ)Greater than0.05-1.286
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Reviva Pharmaceuticals Holdings Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.576
Ma 20Greater thanMa 503.452
Ma 50Greater thanMa 1003.592
Ma 100Greater thanMa 2003.893
OpenGreater thanClose3.010
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets18,924
Total Liabilities6,607
Total Stockholder Equity12,316
 As reported
Total Liabilities 6,607
Total Stockholder Equity+ 12,316
Total Assets = 18,924

Assets

Total Assets18,924
Total Current Assets18,924
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 18,520
Other Current Assets 404
Total Current Assets  (as reported)18,924
Total Current Assets  (calculated)18,924
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,040
Long-term Liabilities567
Total Stockholder Equity12,316
Total Current Liabilities
Accounts payable 3,520
Other Current Liabilities 2,520
Total Current Liabilities  (as reported)6,040
Total Current Liabilities  (calculated)6,040
+/-0
Long-term Liabilities
Other Liabilities 567
Long-term Liabilities  (as reported)567
Long-term Liabilities  (calculated)567
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -91,171
Other Stockholders Equity 103,486
Total Stockholder Equity (as reported)12,316
Total Stockholder Equity (calculated)12,316
+/-0
Other
Capital Stock2
Cash and Short Term Investments 18,520
Common Stock Shares Outstanding 19,516
Liabilities and Stockholders Equity 18,924
Net Debt -18,520
Net Invested Capital 12,316
Net Tangible Assets 12,316
Net Working Capital 12,884



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-31
> Total Assets 
0
3
8,762
31,404
18,924
18,92431,4048,76230
   > Total Current Assets 
119
0
8,760
31,404
18,924
18,92431,4048,7600119
       Cash And Cash Equivalents 
0
0
8,760
29,688
18,520
18,52029,6888,76000
       Short-term Investments 
0
65,242
0
0
0
00065,2420
       Other Current Assets 
0
0
70
1,716
404
4041,7167000
   > Long-term Assets 
0
2
2
0
0
00220
       Property Plant Equipment 
1
1
42
0
0
004211
       Long-term Assets Other 
0
2
2
0
0
00220
> Total Liabilities 
0
6,814
1,333
2,718
6,607
6,6072,7181,3336,8140
   > Total Current Liabilities 
6,086
6,814
1,333
2,345
6,040
6,0402,3451,3336,8146,086
       Short-term Debt 
0
3,765
0
0
0
0003,7650
       Short Long Term Debt 
0
3,765
0
0
0
0003,7650
       Accounts payable 
66
225
1,008
510
3,520
3,5205101,00822566
       Other Current Liabilities 
108
102
325
1,835
2,520
2,5201,835325102108
   > Long-term Liabilities 
0
3,990
2,964
373
567
5673732,9643,9900
       Other Liabilities 
0
0
1,964
373
567
5673731,96400
> Total Stockholder Equity
0
-6,811
7,430
28,686
12,316
12,31628,6867,430-6,8110
   Common Stock
1
1
1
1
2
21111
   Retained Earnings Total Equity00000
   Accumulated Other Comprehensive Income 000-54,5270
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
0
73,171
65,739
95,517
103,486
103,48695,51765,73973,1710



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-37,289
Operating Income-37,289-37,289
 
Operating Expense (+$)
Research Development29,241
Selling General Administrative8,048
Selling And Marketing Expenses-
Operating Expense37,28937,289
 
Net Interest Income (+$)
Interest Income456
Interest Expense--
Other Finance Cost-20
Net Interest Income436
 
Pretax Income (+$)
Operating Income-37,289
Net Interest Income436
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-37,625-36,518
EBIT - interestExpense = 0
-37,655
-37,655
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--37,625
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-37,625
Tax Provision-30
Net Income From Continuing Ops-37,655-37,655
Net Income-37,655
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-771-436
 

Technical Analysis of Reviva Pharmaceuticals Holdings Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Reviva Pharmaceuticals Holdings Inc.. The general trend of Reviva Pharmaceuticals Holdings Inc. is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Reviva Pharmaceuticals Holdings Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Reviva Pharmaceuticals Holdings Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.81 < 4.05 < 4.07.

The bearish price targets are: 2.67 > 2.62 > 1.56.

Tweet this
Reviva Pharmaceuticals Holdings Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Reviva Pharmaceuticals Holdings Inc.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Reviva Pharmaceuticals Holdings Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Reviva Pharmaceuticals Holdings Inc.. The current macd is -0.13405927.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Reviva Pharmaceuticals Holdings Inc. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Reviva Pharmaceuticals Holdings Inc.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Reviva Pharmaceuticals Holdings Inc. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Reviva Pharmaceuticals Holdings Inc. Daily Moving Average Convergence/Divergence (MACD) ChartReviva Pharmaceuticals Holdings Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Reviva Pharmaceuticals Holdings Inc.. The current adx is 20.86.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Reviva Pharmaceuticals Holdings Inc. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Reviva Pharmaceuticals Holdings Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Reviva Pharmaceuticals Holdings Inc.. The current sar is 3.79386705.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Reviva Pharmaceuticals Holdings Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Reviva Pharmaceuticals Holdings Inc.. The current rsi is 37.58. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Reviva Pharmaceuticals Holdings Inc. Daily Relative Strength Index (RSI) ChartReviva Pharmaceuticals Holdings Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Reviva Pharmaceuticals Holdings Inc.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Reviva Pharmaceuticals Holdings Inc. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Reviva Pharmaceuticals Holdings Inc. Daily Stochastic Oscillator ChartReviva Pharmaceuticals Holdings Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Reviva Pharmaceuticals Holdings Inc.. The current cci is -120.62766754.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Reviva Pharmaceuticals Holdings Inc. Daily Commodity Channel Index (CCI) ChartReviva Pharmaceuticals Holdings Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Reviva Pharmaceuticals Holdings Inc.. The current cmo is -35.16368918.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Reviva Pharmaceuticals Holdings Inc. Daily Chande Momentum Oscillator (CMO) ChartReviva Pharmaceuticals Holdings Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Reviva Pharmaceuticals Holdings Inc.. The current willr is -86.81318681.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Reviva Pharmaceuticals Holdings Inc. Daily Williams %R ChartReviva Pharmaceuticals Holdings Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Reviva Pharmaceuticals Holdings Inc..

Reviva Pharmaceuticals Holdings Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Reviva Pharmaceuticals Holdings Inc.. The current atr is 0.26716214.

Reviva Pharmaceuticals Holdings Inc. Daily Average True Range (ATR) ChartReviva Pharmaceuticals Holdings Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Reviva Pharmaceuticals Holdings Inc.. The current obv is 99,331,558.

Reviva Pharmaceuticals Holdings Inc. Daily On-Balance Volume (OBV) ChartReviva Pharmaceuticals Holdings Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Reviva Pharmaceuticals Holdings Inc.. The current mfi is 31.12.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Reviva Pharmaceuticals Holdings Inc. Daily Money Flow Index (MFI) ChartReviva Pharmaceuticals Holdings Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Reviva Pharmaceuticals Holdings Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Reviva Pharmaceuticals Holdings Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Reviva Pharmaceuticals Holdings Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.576
Ma 20Greater thanMa 503.452
Ma 50Greater thanMa 1003.592
Ma 100Greater thanMa 2003.893
OpenGreater thanClose3.010
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Reviva Pharmaceuticals Holdings Inc. with someone you think should read this too:
  • Are you bullish or bearish on Reviva Pharmaceuticals Holdings Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Reviva Pharmaceuticals Holdings Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Reviva Pharmaceuticals Holdings Inc.

I send you an email if I find something interesting about Reviva Pharmaceuticals Holdings Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Reviva Pharmaceuticals Holdings Inc..

Receive notifications about Reviva Pharmaceuticals Holdings Inc. in your mailbox!